학술논문
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin
Document Type
Article
Author
Source
In: BJU International . (BJU International, 1 August 2020, 126(2):292-299)
Subject
Language
English
ISSN
1464410X
14644096
14644096